TTNP

Titan Pharmaceuticals
TTNP

Overview Fund Trends Analyst Outlook
Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

16 hedge funds and large institutions have $230K invested in Titan Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
–
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TRCT
Tower Research Capital (TRC)
New York
+$4.08K
2
MA
MCF Advisors
Kentucky
+$1.18K
3
Osaic Holdings
Osaic Holdings
Arizona
+$56
4
Morgan Stanley
Morgan Stanley
New York
+$21
5
Bank of America
Bank of America
North Carolina
+$14

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$56K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$33.8K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$29K
4
State Street
State Street
Massachusetts
-$15.8K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$8.08K
Name Holding Trade Value Shares
Change 		Shares
Change %
Qube Research & Technologies (QRT)
26
Qube Research & Technologies (QRT)
United Kingdom
– -$2 – –
NFSG
27
Newbridge Financial Services Group
Florida
– -$1 – –
1
2